LADENBURG THALMANN FINANCIAL SERVICES INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2019$95,000
-10.4%
819
-2.7%
0.00%0.0%
Q3 2019$106,000
+19.1%
842
+13.2%
0.00%0.0%
Q2 2019$89,000
-59.7%
744
-70.4%
0.00%
-50.0%
Q1 2019$221,000
+172.8%
2,513
+208.3%
0.00%
+100.0%
Q4 2018$81,000
+12.5%
815
+31.0%
0.00%0.0%
Q3 2018$72,000
-8.9%
622
-42.8%
0.00%0.0%
Q2 2018$79,0000.0%1,0870.0%0.00%0.0%
Q1 2018$79,000
+29.5%
1,087
+2.6%
0.00%0.0%
Q4 2017$61,000
+48.8%
1,059
+15.6%
0.00%
Q3 2017$41,000
+7.9%
916
-3.9%
0.00%
Q2 2017$38,000
+26.7%
953
+28.1%
0.00%
Q1 2017$30,000
+114.3%
744
+116.3%
0.00%
Q4 2016$14,0000.0%344
-13.6%
0.00%
Q3 2016$14,000
+75.0%
398
+36.3%
0.00%
Q2 2016$8,000
-80.0%
292
-74.6%
0.00%
-100.0%
Q1 2016$40,000
+66.7%
1,148
+51.5%
0.00%
Q4 2015$24,000
+20.0%
758
+19.9%
0.00%
Q3 2015$20,000
+33.3%
632
+77.0%
0.00%
Q2 2015$15,000
-46.4%
357
-43.1%
0.00%
-100.0%
Q1 2015$28,000
+33.3%
627
+14.0%
0.00%
Q4 2014$21,0000.0%550
-10.1%
0.00%
-100.0%
Q3 2014$21,000
+16.7%
612
+21.4%
0.00%
Q2 2014$18,000
-5.3%
504
-13.4%
0.00%
-100.0%
Q1 2014$19,000
-24.0%
5820.0%0.00%0.0%
Q4 2013$25,000
-10.7%
582
-17.1%
0.00%0.0%
Q3 2013$28,000
+16.7%
702
+20.6%
0.00%0.0%
Q2 2013$24,0005820.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders